This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

NCT00548262 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidemia
Invasive Candidiasis

Interventions

DRUG: Anidulafungin
DRUG: Voriconazole

Sponsor

Pfizer